Home / 2017 / June / 17

Daily Archives: Jun 17, 2017

June 17, 2017

This is our first week back from ADA, and Steve and Joy did a fantastic job getting to the best of the best in the diabetes world. Instead of going old school and focusing on the usual thought leaders, they tried to find the new thinkers and ideas that are …

Read More »

Realistic A1C Targets

Test Your Knowledge

A 78-year old patient with a 15-year history of type 2 diabetes arrives in your office for a check-up. He suffers from stage 3 chronic kidney disease and lives alone. From previous visits you have learned he has very few support services. What would be a realistic A1C treatment target for this individual? A. A1C 6.0-6.5% B. A1C 7.5-8.0% C. A1C 8.5-10.0% D. A1C 10.5-11% Follow the link to see the correct answer!

Read More »

SGLT-2 / GLP-1 Combo

Would you consider using a combination of SGLT-2 Inhibitor along with an GLP-1 Agonist, now or in the future? Follow the link to see how you and your colleagues compare!

Read More »

MedAngel ONE (Protecting Your Insulin From Temperature Changes)

MedAngel ONE is the best solution to monitor and protect temperature sensitive medications like insulin. Continuous monitoring and logging ensures that you and your patients can always can always see beyond doubt if your medications were stored properly. It supports hundreds of FDA approved medications and adapts the smart alerts to them. If a dangerous temperature is approached or exceeded, the app will alert you immediately. Read on for details and for a special discount + Free shipping Use code: Med10.

Read More »

Exclusive: Dr. Bruce Neal Discusses Canagliflozin’s Potential for Heart Failure Prevention

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have an exclusive interview from ADA 2017. The CANVAS study’s outcomes were “a positive first step” in proving that canagliflozin can be used for the primary prevention of heart failure in patients with diabetes, but more evidence is needed, according to the study’s lead author, Dr. Bruce Neal.

Read More »